Ertan DOĞAN, Pınar AKSU KILIÇLE, Abdullah DOĞAN, Dinçer ERDAĞ, Ali Nazmi Can DOĞAN, Kadir ÖZCAN

The protective effects of cysteamine, putrescine, and the combination of cysteamineand putrescine on fibrosarcoma induced in mice with 3-methylcholanthrene

In this study, the protective effects of cysteamine, putrescine, and the combination of cysteamine and putrescine were investigated in mice with fibrosarcoma induced with 3-methylcholanthrene (3-MC). A total of 135 adult male albino mice (Mus musculus), 2 3 months old and weighing 20 ± 2.0 g, were used in this study. All groups (each consisting of 15 mice) were fed ad libitum. The experimental groups were Group 1 (drinking water), Group 2 (0.2 mL sesame oil s.c.), Group 3 (1 mg 3-MC/0.2 mL sesame oil), Group 4 (0.1% cysteamine), Group 5 (0.1% putrescine), Group 6 (0.1% cysteamine + putrescine), Group 7 (1 mg 3-MC/0.2 sesame oil + 0.1% cysteamine), Group 8 (1 mg 3-MC/0.2 mL sesame oil + 0.1% putrescine), and Group 9 (1 mg 3-MC/0.2 mL sesame oil + 0.1% cysteamine + 0.1% putrescine). Experimental groups were given cysteamine and/or putrescine mixed with drinking water right after being injected with 3-MC subcutaneously. After 7 months, the mice were euthanized by means of cervical dislocation and were evaluated morphologically and histopathologically. The results showed that the number of tumors of 3-MC-induced fibrosarcoma were reduced from the highest to the lowest by cysteamine, cysteamine + putrescine, and putrescine, respectively.

PDF

___

1.Doğan A. Toksikoloji Ders Notları. Kars, Turkey: Kafkas Üniversitesi Veteriner Fakültesi, Farmakoloji ve Toksikoloji Anabilim Dalı; 2012 (in Turkish).
2.Forth W, Henschler D, Rummel W, editors. Pharmakologie und Toxikologie.
4. Mannheim, Germany: Völlig Neu Bearbeitete Auflage Bibliographisches Institut; 1983 (in German).
3.Traş B. Genetik toksikoloji. In: Kaya S, Pirinçci İ, Bilgili A, editors. Veteriner Hekimliğinde Toksikoloji. 2nd ed. Ankara, Turkey: Baskı Medisan Yayınları; 2002. pp. 647-670 (in Turkish).
4.Doğan A, Aksu, P, Erdağ D, Bayezıt M, Doğan E, Özcan K. Farelerde 3-metilkolantrenle indüklenen fibrosarkoma üzerine sisteaminin etkileri. Kafkas Üniv Vet Fak Derg 2013; 19: 7-12 (in Turkish).
5.Doğan A, Aksu P, Erdağ D, Özcan K, Doğan E. Farelerde 3-metilkolantrenle indüklenen fibrosarkoma üzerine sisteamin, putresin ve sisteamin-putresin kombinasyonunun etkileri. Kafkas Üniv Vet Fak Derg 2014; 20: 11-19 (in Turkish).
6.Sozmen M, Tunca R, Erginsoy SD. Cyclin A expression is associated with apoptosis and mitosis in murine 3-methylcholanthrene-induced fibrosarcomas. Exper Tox Pathol 2009; 61: 41-49.
7.Sacu D, Bildik A. Deneysel olarak fibrasarkom oluşturulan ratların interlökin 6 (IL-6) ve tümör nekrözis faktör alfa (TNF alfa) düzeylerinin belirlenmesi. Kafkas Üniv Vet Fak Derg 2009; 15: 681-686 (in Turkish).
8.Donovan PJ, Smith GT, Nardone R. The mutagenic effect of 7,12-dimethylbenz[a]anthacene, 3-methylcholanthrene and benzo[a]pyrene to the developing Syrian hamster fetus measured by an in vivo/in vitro mutation assay. Mut Res 2004; 554: 111-117.
9.Lutz CT, Browne G, Petzold CR. Methylcholanthrene causes increased thymocyte apoptosis.Toxicology 1998; 128: 151-167.
10.Celius T, Pansoy A, Mathews J, Okey AB, Henderson MC, Krueger HS, Williams DE. Flavin-containing monooxygenase-3: induction by 3-methylcholanthrene and complex regulation by xenobiotic chemicals in hepatoma cells and mouse liver. Tox Appl Pharm 2010; 247: 60-69.
11.Baijal PK, Fitzpatrick DW, Bird RP. Phenobarbital and 3-methylcholanthrene treatment alters phase I and phase II enzymes and sensitivity of the rat colon to the carcinogenic activity of azoxymethane. Food Chem Toxicol 1997; 35: 789-798.
12.Bentley R. From reactive C2 units to acetyl coenzyme A: a long trail with an acetyl phosphate detour. Trends Biochem Sci 2000; 25: 302-305.
13.Vecsei L, Ekman R, Alling C, Widerlöv E. Influence of cysteamine and cysteine on open-field behaviour, and on brain concentration of catecholamine, somatostatin, neuropeptide Y and corticotropin releasing hormone in the heart. J Neural Transm 1989; 78: 209-220.
14.Basouw M, Levtchenko E. Pharmacokinetics of cysteamine in cystinosis patients treated with hemodialysis. Pediatr Nephrol 2011; 26: 639-640.
15.Wilmer MJ, Kluijtmans LAJ, Van Der Welden TJ, Willems PH, Scheffer PG, Masereeuv M, Monnens LA, Van Den Hauvel LP, Leftchenko EN. Cysteamine restores glutathione redox status in cultured cystinotic proximal tubular epithelial cells. Biochim Biophys Acta 2011; 1812: 643-651.
16.Ruiz-Cano D, Perez-Liamas F, Zamora S. Polyamines, implications for infant health. Arch Argentinos De Pedietria 2012; 110: 244-250 (in Spanish with English abstract).
17.Vargas AJ, Wertheim BC, Gerner EW, Thornson CA, Rock C, Thompson PA. Dietary polyamine intake and risk of colorectal adenomatous polyps. Am J Clin Nut 2012; 96: 133-141.
18.Russo A, Piovano M, Clercuzio M, Lombardo L, Tabasso S, Chamy MC, Vidari G, Cardile V, Vita-Finzi P, Garbarino JA. Putrescin-1,4-dicinnamide from Pholiota spumosa(blasidomycetes) inhibits cell growth of human prostate cancer cells. Phytomedicine 2007; 14: 185-191.
19.Luna LG. Manual of Histologic Staining Methods of the Armed Forces Institute of Pathology. 3rd ed. New York: McGraw-Hill; 1968.
20.Minitab.Minitab Release 12.1. State College, PA, USA: Minitab Inc.; 1998.
21.Keshava N. Tumorigenicity of morphologically distinct transformed foci induced by 3-methylcholanthrene in BALB/c 3-T3 cells. Mut Res 2000; 447: 281-286.
22.Grachev SA, Kropachev EV, Litvyakova GI. Synthesis of 5-S-cysteamine-6-hydroxythymine and evidence of its formation in the gamma radiolysis of aqueous solutions of thymine and cysteamine. Izvestiya Akademii Nauk SSSR Seriya Khimicheskaya 1984; 541: 1595-1599 (in Russian with English abstract).
23. Gebhard H. The anticlastogenic effect of various combinations of cysteamine, AET, HCT and amino acids on chromosome damage by trenimon and bleomycin in human lymphocytes in vitro. Hum Genet 1978; 43: 185-203.
24.Sanina NA, Syrtsova LA, Psikha BL, Shkondina NI, Rudneva TV, Kotelnikov AI, Aldoshin SM. Ferrocytochrome c and deoxyhemoglobin in the reaction with the iron cysteamine nitrosyl complex {Fe2[S(CH2)2NH3]2(NO)4}SO42.5H2O. Russian Chem B+ 2010; 59: 1994-1998.
25.Juan SH, Lee JL, Ho PY, Lee YH, Lee WS. Antiproliferative and antiangiogenic effects of 3-methylcholanthrene an aryl-hydrocarbon receptor agonist in human umbilical vascular endothelial cells. Europ J Pharm 2006; 530: 1-8.
26.Kaskow BJ, Proffit JM, Blangero J, Moses EK, Abraham LJ. Diverse biological activities of the vascular non-inflammatory molecules: the vanin pantetheinases. Biochem Biopys Res Commun 2012; 417: 653-658.
27.Takao K, Rickhag M, Hegardt C, Oredsson S, Persson L. Induction of apoptotic cell death by putrescine. Inter J Biochem Cell Biol 2006; 38: 621-628.
28.Milovica V, Turchanowa L, Khomutov AL, Khomutow RM, Caspary WF, Stein J. Hydroxylamine-containing inhibitors of polyamine biosynthesis and impairment of colon cancer cell growth. Biochem Pharm 2001; 61: 199-206.
29.Peterson LA, Phillips MB, Lu D, Sullivan MM. Polyamines are traps for reactive intermediates in furan metabolism. Chem Res Toxicol 2011; 24: 1924-1936.
30.Khuhawan MY, Qureshis GA. Polyamines as cancer markers: applicable separation methods. J Chrom B 2001; 764: 385-407.